SecSonar.com

Cerus Corporation (CERS)

Cerus Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Cerus Corporation (CERS) is a Medical - Devices company based in US with a market capitalization of $612.8M. Revenue grew 14.3% year-over-year and the company generated $8.5M in free cash flow. This page tracks CERS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 614 employees · IPO Jan 31, 1997

Valuation

Valuation & price

$2.34 · as of May 17, 2026 · -25.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

9.54

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$3.16$2.17$1.19Jul 25Dec 25Jul 26Jul 7, 25$1.45Jul 9, 25$1.49Jul 11, 25$1.45Jul 15, 25$1.35Jul 17, 25$1.37Jul 21, 25$1.38Jul 23, 25$1.45Jul 25, 25$1.39Jul 29, 25$1.33Jul 31, 25$1.28Aug 4, 25$1.30Aug 6, 25$1.29Aug 11, 25$1.25Aug 13, 25$1.33Aug 15, 25$1.24Aug 19, 25$1.19Aug 21, 25$1.20Aug 25, 25$1.28Aug 27, 25$1.31Aug 29, 25$1.31Sep 3, 25$1.31Sep 5, 25$1.33Sep 9, 25$1.29Sep 11, 25$1.25Sep 16, 25$1.26Sep 18, 25$1.30Sep 22, 25$1.51Sep 24, 25$1.54Sep 26, 25$1.44Sep 30, 25$1.59Oct 2, 25$1.51Oct 6, 25$1.61Oct 8, 25$1.68Oct 10, 25$1.60Oct 14, 25$1.58Oct 16, 25$1.58Oct 21, 25$1.64Oct 23, 25$1.51Oct 27, 25$1.54Oct 29, 25$1.45Oct 31, 25$1.47Nov 4, 25$1.45Nov 6, 25$1.41Nov 10, 25$1.60Nov 12, 25$1.65Nov 14, 25$1.62Nov 18, 25$1.49Nov 20, 25$1.49Nov 25, 25$1.77Nov 28, 25$1.76Dec 2, 25$1.87Dec 4, 25$2.10Dec 8, 25$1.87Dec 10, 25$1.89Dec 12, 25$2.18Dec 16, 25$2.16Dec 18, 25$2.15Dec 22, 25$2.12Dec 24, 25$2.06Dec 29, 25$2.06Jan 2, 26$1.97Jan 6, 26$2.07Jan 8, 26$2.09Jan 12, 26$2.27Jan 14, 26$2.74Jan 16, 26$2.60Jan 21, 26$2.53Jan 23, 26$2.49Jan 27, 26$2.49Jan 29, 26$2.32Feb 2, 26$2.32Feb 4, 26$2.29Feb 9, 26$2.18Feb 11, 26$2.15Feb 13, 26$2.24Feb 18, 26$2.47Feb 20, 26$2.41Feb 24, 26$2.38Feb 26, 26$2.60Mar 2, 26$2.53Mar 4, 26$2.24Mar 6, 26$1.93Mar 10, 26$1.77Mar 12, 26$1.70Mar 17, 26$1.80Mar 19, 26$1.76Mar 23, 26$1.82Mar 25, 26$1.84Mar 27, 26$1.78Mar 31, 26$1.82Apr 2, 26$1.86Apr 7, 26$1.84Apr 9, 26$1.91Apr 13, 26$1.92Apr 15, 26$2.02Apr 17, 26$2.08Apr 22, 26$1.94Apr 24, 26$1.98Apr 28, 26$1.97Apr 30, 26$2.03May 4, 26$2.72May 6, 26$2.59May 8, 26$2.61May 12, 26$2.55May 14, 26$2.51May 18, 26$2.43May 20, 26$2.69May 22, 26$2.71May 28, 26$2.92Jun 1, 26$2.84Jun 3, 26$2.66Jun 5, 26$2.71Jun 9, 26$2.58Jun 11, 26$2.59Jun 15, 26$2.52Jun 17, 26$2.57Jun 22, 26$2.60Jun 24, 26$2.64Jun 26, 26$2.92Jul 2, 26$3.16
$1.1652-week range$3.16
Loading valuation history…

Fundamentals

Key fundamentals

$612.8M

Market cap

14.3%

Revenue growth (YoY)

53.5%

Gross margin

$8.5M

Free cash flow (USD)

$14.1M

Net debt

3.3%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$37.2MFY 2017$43.6MFY 2018$60.9MFY 2019$74.6MFY 2020$91.9MFY 2021$130.9MFY 2022$162.0MFY 2023$156.4MFY 2024$180.3MFY 2025$206.1M
$37.2M$206.1M

Free cash flow by year

2016 → 2025

FY 2016$-54.1MFY 2017$-52.6MFY 2018$-32.4MFY 2019$-74.4MFY 2020$-43.4MFY 2021$-34.8MFY 2022$-27.6MFY 2023$-47.8MFY 2024$8.5MFY 2025$8.5M
-$54.1M$8.5M

Gross margin by year

2021 → 2025

FY 202151.5%FY 202253.8%FY 202355.3%FY 202455.2%FY 202553.5%
51.5%53.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

7

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 30, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $99K · 10b5-1 PlanGreen Kevin Dennis · Chief Financial Officer · $99.1KJul 2, 2026Filing
  • Insider sellInsider Sell $300K · 10b5-1 PlanGreenman William Mariner · Director, President and CEO · $299.9KJul 2, 2026Filing
  • Insider sellInsider Sell $72K · 10b5-1 PlanJensen Chrystal · Chief Legal Officer · $71.6KJul 2, 2026Filing
  • Insider sellInsider Sell $125K · 10b5-1 PlanJayaraman Vivek K · Chief Operating Officer · $124.7KJul 2, 2026Filing
  • Insider sellInsider Sell $53KBJERKHOLT ERIC · Director · $53.2KJun 11, 2026Filing
  • 8-K eventDebt RefinancingJun 8, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 3, 2026Filing
  • Insider sellInsider Sell $50K · 10b5-1 PlanJayaraman Vivek K · Chief Operating Officer · $50KJun 2, 2026Filing
  • Insider sellInsider Sell $50K · 10b5-1 PlanJayaraman Vivek K · Chief Operating Officer · $50KMay 5, 2026Filing
  • 8-K eventEarnings ReleaseApr 30, 2026Filing

Questions

Frequently asked questions

What is Cerus Corporation's market cap?

Cerus Corporation (CERS) has a market capitalization of $612.8M.

What is CERS's P/E ratio?

A meaningful P/E ratio is not available for CERS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is CERS's price-to-book (P/B) ratio?

CERS trades at 9.54 times book value per share.

Are insiders buying CERS stock?

SEC Form 4 filings show no open-market insider buys at Cerus Corporation in the last 90 days (7 sells).

Same arena

Related companies in Medical - Devices

BWAY

BrainsWay Ltd.

$613.4M

SIBN

SI-BONE, Inc.

$631.8M

NPCE

NeuroPace, Inc.

$590.8M

BVS

Bioventus Inc.

$580.6M

TCMD

Tactile Systems Technology, Inc.

$560.5M

CTKB

Cytek Biosciences, Inc.

$551.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.